BioLife Solutions, Inc.

General ticker "BLFS" information:

  • Sector: Health Care
  • Industry: Medical - Instruments & Supplies
  • Capitalization: $1.2B (TTM average)

BioLife Solutions, Inc. follows the US Stock Market performance with the rate: 41.2%.

Estimated limits based on current volatility of 4.4%: low 19.95$, high 21.78$

Factors to consider:

  • Total employees count: 159 (-61.6%) as of 2024
  • Top business risk factors: Pandemic risks, Product performance, Labor/talent shortage/retention, Manufacturing risks, Litigation risks
  • Price in estimated range
  • Earnings for 12 months up through Q4 are below our estimates

Stock Forecast*

* forecast is subjective and experimental, should not be used for any investment decisions

Long term estimates were made for the period from 2024-12-31 to 2026-12-31

  • 2024-12-31 to 2025-12-31 estimated range: [17.98$, 29.15$]
  • 2025-12-31 to 2026-12-31 estimated range: [16.86$, 27.65$]

Similar symbols

Short-term BLFS quotes

Long-term BLFS plot with estimates

Financial data

YTD 2023-12-31 2024-12-31 2025-12-31
Operating Revenue $75.86MM $82.25MM $96.21MM
Operating Expenses $99.30MM $89.38MM $108.34MM
Operating Income $-23.44MM $-7.13MM $-12.13MM
Non-Operating Income $4.97MM $-4.30MM $0.05MM
Interest Expense $1.45MM $0.72MM $2.71MM
R&D Expense $12.07MM $7.91MM $7.57MM
Income(Loss) $-18.47MM $-11.43MM $-12.08MM
Taxes $-0.02MM $-0.04MM $0.05MM
Other Income(Loss) $-49.55MM $-8.80MM $0.00MM
Profit(Loss)* $-66.43MM $-28.98MM $-24.26MM
Stockholders Equity $337.66MM $348.91MM $371.89MM
Inventory $43.46MM $29.01MM $0.00MM
Assets $412.71MM $399.49MM $405.88MM
Operating Cash Flow $-12.50MM $8.43MM $20.11MM
Capital expenditure $6.38MM $3.23MM $0.00MM
Investing Cash Flow $17.84MM $58.30MM $-71.54MM
Financing Cash Flow $10.59MM $-6.78MM $-10.92MM
Earnings Per Share** $-1.52 $-0.63 $-0.51

* Profit(Loss) attributable to entity.
** EPS are Split Adjusted, recent splits may be reflected with a delay.